IUPAC name
3-[(1S)-1-(dimethylamino)ethyl]phenyl N-ethyl-N-methylcarbamate
SMILES
CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C
Compound class
Neuroprotective Agents; Cholinesterase Inhibitors; Cholinergic Agents; Nervous System; Psychoanaleptics; Anticholinesterases; Anti-Dementia Drugs; CYP2D6 Inducers; CYP2D6 Inducers (strong); CYP3A4 Inhibitors;
Therapeutic area
For the treatment of mild to moderate dementia associated with Parkinson's disease or of the Alzheimer's type.
Common name
Rivastigmine
IUPAC name
3-[(1S)-1-(dimethylamino)ethyl]phenyl N-ethyl-N-methylcarbamate
SMILES
CCN(C)C(=O)OC1=CC=CC(=C1)[C@H](C)N(C)C
INCHI
InChI=1S/C14H22N2O2/c1-6-16(5)14(17)18-13-9-7-8-12(10-13)11(2)15(3)4/h7-11H,6H2,1-5H3/t11-/m0/s1
FORMULA
C14H22N2O2
Common name
Rivastigmine
IUPAC name
3-[(1S)-1-(dimethylamino)ethyl]phenyl N-ethyl-N-methylcarbamate
Molecular weight
250.337
clogP
1.455
clogS
-2.549
HBond Acceptor
3
HBond Donor
0
Total Polar Surface Area
32.78
Number of Rings
1
Rotatable Bond
6
| Drug ID | Common name | Structure CAS | SMILE | Frequency |
|---|---|---|---|---|
| FDBF00005 | benzene |
|
c1ccccc1 | 0.2824 |
| FDBF00066 | N-methylmethanamine |
|
N(C)C | 0.0914 |
| FDBF00141 | ethylbenzene |
|
c1(ccccc1)CC | 0.0371 |
| FDBF00289 | N,N-dimethylethanamine |
|
C(C)N(C)C | 0.0299 |
| FDBF01127 | methylcarbamic acid |
|
O=C(O)NC | 0.0199 |
| FDBF02121 | phenyl N-methylcarbamate |
|
c1cc(ccc1)OC(=O)NC | 0.0045 |
| FDBF02125 | ethyl(methyl)carbamic acid |
|
O=C(O)N(C)CC | 0.0007 |
| FDBF02228 | (3-ethylphenyl) N-methylcarbamate |
|
C(C)c1cc(ccc1)OC(=O)NC | 0.0007 |
| FDBF02229 | (1S)-N,N-dimethyl-1-phenyl-ethanamine |
|
C(C)(c1ccccc1)N(C)C | 0.0003 |
9 ,
1
